Chemogenomic profiling of the cellular effects associated with histone H3 acetylation impairment by a quinoline-derived compound

Genomics

Volumn 96, Issue 5, 2010, Pages 272-280

  Ruotolo, Roberta ^a   Tosi, Federica ^b   Vernarecci, Stefano ^b   Ballario, Paola ^c   Mai, Antonello ^c   Filetici, Patrizia ^b   Ottonello, Simone ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b CNR   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acetylation inhibitor; Chemogenomics; Gcn5 Rtt109 HAT; Genome wide deletion mutant collection; Histone acetyltransferase; Yeast

Indexed keywords

ANACARDIC ACID; DNA; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE GCN5; HISTONE ACETYLTRANSFERASE RTT109; HISTONE H3; LYSINE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CHEMICAL GENETICS; CHEMOGENOMIC PROFILING; CONTROLLED STUDY; CYTOSKELETON; DNA HISTONE INTERACTION; DNA REPAIR; GENE DELETION; GENETIC ASSOCIATION; GENOMICS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; YEAST;

ACETYLATION; GENE DELETION; GENE EXPRESSION PROFILING; HISTONE ACETYLTRANSFERASES; HISTONES; MICROBIAL SENSITIVITY TESTS; MULTIPROTEIN COMPLEXES; MUTATION; QUINOLINES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 78649448009     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2010.08.005     Document Type: Article

References (55)

1. Roth S.Y., Denu J.M., Allis C.D. Histone acetyltransferases. Annu. Rev. Biochem. 2001, 70:81-120.
2. Marmorstein R. Structure and function of histone acetyltransferases. Cell. Mol. Life Sci. 2001, 58:693-703.
3. Tang Y., Holbert M.A., Wurtele H., Meeth K., Rocha W., Gharib M., Jiang E., Thibault P., Verreault A., Cole P.A., Marmorstein R. Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat. Struct. Mol. Biol. 2008, 15:738-745.
4. Lee K.K., Workman J.L. Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell Biol. 2007, 8:284-295.
5. Berndsen C.E., Tsubota T., Lindner S.E., Lee S., Holton J.M., Kaufman P.D., Keck J.L., Denu J.M. Molecular functions of the histone acetyltransferase chaperone complex Rtt109-Vps75. Nat. Struct. Mol. Biol. 2008, 15:948-956.
6. Yang X.J. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res. 2004, 32:959-976.
7. Lafon-Hughes L., Di Tomaso M.V., Mendez-Acuna L., Martinez-Lopez W. Chromatin-remodelling mechanisms in cancer. Mutat. Res. 2008, 658:191-214.
8. Redner R.L., Wang J., Liu J.M. Chromatin remodeling and leukemia: new therapeutic paradigms. Blood 1999, 94:417-428.
9. Lin W., Zhang Z., Srajer G., Chen Y.C., Huang M., Phan H.M., Dent S.Y. Proper expression of the Gcn5 histone acetyltransferase is required for neural tube closure in mouse embryos. Dev. Dyn. 2008, 237:928-940.
10. Rojas J.R., Trievel R.C., Zhou J., Mo Y., Li X., Berger S.L., Allis C.D., Marmorstein R. Structure of Tetrahymena GCN5 bound to coenzyme A and a histone H3 peptide. Nature 1999, 401:93-98.
11. Owen D.J., Ornaghi P., Yang J.C., Lowe N., Evans P.R., Ballario P., Neuhaus D., Filetici P., Travers A.A. The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J. 2000, 19:6141-6149.
12. Inche A.G., La Thangue N.B. Chromatin control and cancer-drug discovery: realizing the promise. Drug Discov. Today 2006, 11:97-109.
13. Kazantsev A.G., Thompson L.M. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat. Rev. Drug Discov. 2008, 7:854-868.
14. Minucci S., Pelicci P.G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 2006, 6:38-51.
15. Balasubramanyam K., Swaminathan V., Ranganathan A., Kundu T.K. Small molecule modulators of histone acetyltransferase p300. J. Biol. Chem. 2003, 278:19134-19140.
16. Sung B., Pandey M.K., Ahn K.S., Yi T., Chaturvedi M.M., Liu M., Aggarwal B.B. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 2008, 111:4880-4891.
17. Balasubramanyam K., Altaf M., Varier R.A., Swaminathan V., Ravindran A., Sadhale P.P., Kundu T.K. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J. Biol. Chem. 2004, 279:33716-33726.
18. Balasubramanyam K., Varier R.A., Altaf M., Swaminathan V., Siddappa N.B., Ranga U., Kundu T.K. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 2004, 279:51163-51171.
19. Mai A., Rotili D., Tarantino D., Ornaghi P., Tosi F., Vicidomini C., Sbardella G., Nebbioso A., Miceli M., Altucci L., Filetici P. Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties. J. Med. Chem. 2006, 49:6897-6907.
20. Selvi R.B., Kundu T.K. Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics. Biotechnol. J. 2009, 4:375-390.
21. Ornaghi P., Rotili D., Sbardella G., Mai A., Filetici P. A novel Gcn5p inhibitor represses cell growth, gene transcription and histone acetylation in budding yeast. Biochem. Pharmacol. 2005, 70:911-917.
22. Smith A.T., Livingston M.R., Mai A., Filetici P., Queener S.F., Sullivan W.J. Quinoline derivative MC1626, a putative GCN5 histone acetyltransferase (HAT) inhibitor, exhibits HAT-independent activity against Toxoplasma gondii. Antimicrob. Agents Chemother. 2007, 51:1109-1111.
23. Mai A., Rotili D., Tarantino D., Nebbioso A., Castellano S., Sbardella G., Tini M., Altucci L. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases. Bioorg. Med. Chem. Lett. 2009, 19:1132-1135.
24. Berndsen C.E., Denu J.M. Catalysis and substrate selection by histone/protein lysine acetyltransferases. Curr. Opin. Struct. Biol. 2008, 18:682-689.
25. Burgess R.J., Zhou H., Han J., Zhang Z. A role for Gcn5 in replication-coupled nucleosome assembly. Mol. Cell 2010, 37:469-480.
26. Fillingham J., Recht J., Silva A.C., Suter B., Emili A., Stagljar I., Krogan N.J., Allis C.D., Keogh M.C., Greenblatt J.F. Chaperone control of the activity and specificity of the histone H3 acetyltransferase Rtt109. Mol. Cell. Biol. 2008, 28:4342-4353.
27. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 2000, 64:435-459.
28. Scholes D.T., Banerjee M., Bowen B., Curcio M.J. Multiple regulators of Ty1 transposition in Saccharomyces cerevisiae have conserved roles in genome maintenance. Genetics 2001, 159:1449-1465.
29. Driscoll R., Hudson A., Jackson S.P. Yeast Rtt109 promotes genome stability by acetylating histone H3 on lysine 56. Science 2007, 315:649-652.
30. Han J., Zhou H., Horazdovsky B., Zhang K., Xu R.M., Zhang Z. Rtt109 acetylates histone H3 lysine 56 and functions in DNA replication. Science 2007, 315:653-655.
31. Schneider J., Bajwa P., Johnson F.C., Bhaumik S.R., Shilatifard A. Rtt109 is required for proper H3K56 acetylation: a chromatin mark associated with the elongating RNA polymerase II. J. Biol. Chem. 2006, 281:37270-37274.
32. Fehrenbacher K.L., Yang H.C., Gay A.C., Huckaba T.M., Pon L.A. Live cell imaging of mitochondrial movement along actin cables in budding yeast. Curr. Biol. 2004, 14:1996-2004.
33. Leadsham J.E., Gourlay C.W. Cytoskeletal induced apoptosis in yeast. Biochim. Biophys. Acta 2008, 1783:1406-1412.
34. Yaffe M.P. The machinery of mitochondrial inheritance and behavior. Science 1999, 283:1493-1497.
35. Breitenbach M., Laun P., Gimona M. The actin cytoskeleton, RAS-cAMP signaling and mitochondrial ROS in yeast apoptosis. Trends Cell Biol. 2005, 15:637-639.
36. Watanabe M., Watanabe D., Nogami S., Morishita S., Ohya Y. Comprehensive and quantitative analysis of yeast deletion mutants defective in apical and isotropic bud growth. Curr. Genet. 2009, 55:365-380.
37. Vernarecci S., Ornaghi P., Bagu A., Cundari E., Ballario P., Filetici P. Gcn5p plays an important role in centromere kinetochore function in budding yeast. Mol. Cell. Biol. 2008, 28:988-996.
38. Castedo M., Perfettini J.L., Roumier T., Valent A., Raslova H., Yakushijin K., Horne D., Feunteun J., Lenoir G., Medema R., Vainchenker W., Kroemer G. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 2004, 23:4362-4370.
39. Harrison J.C., Bardes E.S., Ohya Y., Lew D.J. A role for the Pkc1p/Mpk1p kinase cascade in the morphogenesis checkpoint. Nat. Cell Biol. 2001, 3:417-420.
40. Aouida M., Page N., Leduc A., Peter M., Ramotar D. A genome-wide screen in Saccharomyces cerevisiae reveals altered transport as a mechanism of resistance to the anticancer drug bleomycin. Cancer Res. 2004, 64:1102-1109.
41. Chang M., Bellaoui M., Boone C., Brown G.W. A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16934-16939.
42. Parsons A.B., Brost R.L., Ding H., Li Z., Zhang C., Sheikh B., Brown G.W., Kane P.M., Hughes T.R., Boone C. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 2004, 22:62-69.
43. Thorpe G.W., Fong C.S., Alic N., Higgins V.J., Dawes I.W. Cells have distinct mechanisms to maintain protection against different reactive oxygen species: oxidative-stress-response genes. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6564-6569.
44. Lundin C., North M., Erixon K., Walters K., Jenssen D., Goldman A.S., Helleday T. Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks. Nucleic Acids Res. 2005, 33:3799-3811.
45. Steighner R.J., Povirk L.F. Bleomycin-induced DNA lesions at mutational hot spots: implications for the mechanism of double-strand cleavage. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:8350-8354.
46. Levin N.A., Bjornsti M.A., Fink G.R. A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest. Genetics 1993, 133:799-814.
47. Ramey C.J., Howar S., Adkins M., Linger J., Spicer J., Tyler J.K. Activation of the DNA damage checkpoint in yeast lacking the histone chaperone anti-silencing function 1. Mol. Cell. Biol. 2004, 24:10313-10327.
48. Masumoto H., Hawke D., Kobayashi R., Verreault A. A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature 2005, 436:294-298.
49. Dinant C., Houtsmuller A.B., Vermeulen W. Chromatin structure and DNA damage repair. Epigenetics Chromatin 2008, 1:9.
50. Marcu M.G., Jung Y.J., Lee S., Chung E.J., Lee M.J., Trepel J., Neckers L. Curcumin is an inhibitor of p300 histone acetylatransferase. Med. Chem. 2006, 2:169-174.
51. Jin Y., Rodriguez A.M., Wyrick J.J. Genetic and genomewide analysis of simultaneous mutations in acetylated and methylated lysine residues in histone H3 in Saccharomyces cerevisiae. Genetics 2009, 181:461-472.
52. Yamaki M., Umehara T., Chimura T., Horikoshi M. Cell death with predominant apoptotic features in Saccharomyces cerevisiae mediated by deletion of the histone chaperone ASF1/CIA1. Genes Cells 2001, 6:1043-1054.
53. Madiraju P., Pande S.V., Prentki M., Madiraju S.R. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics 2009, 4:399-403.
54. Ruotolo R., Marchini G., Ottonello S. Membrane transporters and protein traffic networks differentially affecting metal tolerance: a genomic phenotyping study in yeast. Genome Biol. 2008, 9:R67.
55. Kushnirov V.V. Rapid and reliable protein extraction from yeast. Yeast 2000, 16:857-860.